scholarly article | Q13442814 |
P2093 | author name string | Kenneth G Mann | |
P2860 | cites work | Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications | Q24561689 |
Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C: prediction of a cofactor to activated protein C | Q24563608 | ||
Complete cDNA and derived amino acid sequence of human factor V | Q24605169 | ||
Vitamin K Dependent Modifications of Glutamic Acid Residues in Prothrombin | Q24620022 | ||
Factor V: a combination of Dr Jekyll and Mr Hyde | Q28209649 | ||
The contribution of bovine Factor V and Factor Va to the activity of prothrombinase | Q28249212 | ||
Activation of human prothrombin by human prothrombinase. Influence of factor Va on the reaction mechanism | Q28305220 | ||
Vitamin K-dependent carboxylase | Q28306468 | ||
Primary structure of human prethrombin 2 and alpha-thrombin | Q28611755 | ||
Cooperative activation of human factor IX by the human extrinsic pathway of blood coagulation | Q28630211 | ||
The reliability of molecular weight determinations by dodecyl sulfate-polyacrylamide gel electrophoresis | Q29053311 | ||
Ratcheting of the substrate from the zymogen to proteinase conformations directs the sequential cleavage of prothrombin by prothrombinase | Q33895760 | ||
A Protein Sequenator | Q34054588 | ||
Parahaemophilia; haemorrhagic diathesis due to absence of a previously unknown clotting factor | Q34104996 | ||
WATERFALL SEQUENCE FOR INTRINSIC BLOOD CLOTTING. | Q34257361 | ||
Characterization of the molecular defect in factor VR506Q | Q72591739 | ||
Regulation of tissue factor initiated thrombin generation by the stoichiometric inhibitors tissue factor pathway inhibitor, antithrombin-III, and heparin cofactor-II | Q73039117 | ||
Thrombin functions during tissue factor-induced blood coagulation | Q74314270 | ||
A model describing the inactivation of factor Va by APC: bond cleavage, fragment dissociation, and product inhibition | Q77807397 | ||
THE ACTIVATION OF STUART FACTOR (FACTOR X) BY ACTIVATED ANTIHEMOPHILIC FACTOR (ACTIVATED FACTOR 8) | Q78331107 | ||
Mutation in blood coagulation factor V associated with resistance to activated protein C. | Q34340007 | ||
Fusion between immunoglobulin-secreting and nonsecreting myeloma cell lines | Q34345829 | ||
The tissue factor requirement in blood coagulation | Q34360277 | ||
The crystal structure of activated protein C-inactivated bovine factor Va: Implications for cofactor function | Q34829515 | ||
Activation of factor IX by the reaction product of tissue factor and factor VII: additional pathway for initiating blood coagulation | Q35047906 | ||
Isolation of functional human coagulation factor V by using a hybridoma antibody | Q35302079 | ||
Identification of the polypeptide chains involved in the cross-linking of fibrin | Q36449299 | ||
Inflammation and the activated protein C anticoagulant pathway | Q36467895 | ||
Systemic blood coagulation activation in acute coronary syndromes | Q37116951 | ||
Surface-dependent reactions of the vitamin K-dependent enzyme complexes | Q37938426 | ||
The role of factor V in the assembly of the prothrombinase complex | Q40312885 | ||
Interactions of a fluorescent active-site-directed inhibitor of thrombin: dansylarginine N-(3-ethyl-1,5-pentanediyl)amide | Q41482286 | ||
The chemistry of the activation of prothombin | Q41951951 | ||
Role of magnesium in factor XIa catalyzed activation of factor IX: calcium binding to factor IX under physiologic magnesium | Q41998414 | ||
Simvastatin depresses blood clotting by inhibiting activation of prothrombin, factor V, and factor XIII and by enhancing factor Va inactivation | Q43600847 | ||
Molecular cloning of the cDNA for tissue factor, the cellular receptor for the initiation of the coagulation protease cascade. | Q43675321 | ||
Analysis of the kinetics of prothrombin activation and evidence that two equilibrating forms of prothrombinase are involved in the process | Q44258994 | ||
Purification of six human vitamin K-dependent proteins in a single chromatographic step using immunoaffinity columns | Q44583995 | ||
Differentiation of metal ion-induced transitions of prothrombin fragment 1 | Q45070524 | ||
Blood coagulation in hemophilia A and hemophilia C. | Q45887648 | ||
A model for the stoichiometric regulation of blood coagulation. | Q52044713 | ||
"Normal" thrombin generation. | Q52204026 | ||
A model for the tissue factor pathway to thrombin. II. A mathematical simulation. | Q52371258 | ||
"Clotspeed," a mathematical simulation of the functional properties of prothrombinase. | Q52695848 | ||
Multiple active forms of thrombin. 3. Polypeptide chain location of active site serine and carbohydrate. | Q52948825 | ||
The Estimation of Polypeptide Chain Molecular Weights by Gel Filtration in 6 M Guanidine Hydrochloride | Q53013606 | ||
Amino-Acid Sequence Investigations of Fibrinopeptides from Various Mammals: Evolutionary Implications | Q59054159 | ||
Prothrombin fragments. Ca2+ binding and activation kinetics | Q66913473 | ||
Molecular Changes Associated with Proteolysis of Bovine Factor V by Thrombin | Q67324043 | ||
Isolation and characterization of single chain bovine factor V | Q67469037 | ||
The subunit structure of thrombin-activated factor V. Isolation of activated factor V, separation of subunits, and reconstitution of biological activity | Q67469084 | ||
Thrombin-catalyzed activation of single chain bovine factor V | Q67469113 | ||
Prothrombinase complex assembly. Kinetic mechanism of enzyme assembly on phospholipid vesicles | Q68275360 | ||
A plausible mechanism for prothrombin activation by factor Xa, factor Va, phospholipid, and calcium ions | Q68830409 | ||
Multiple active forms of thrombin. I. Partial resolution, differential activities, and sequential formation | Q70592529 | ||
Characterization of the purified vitamin K-dependent gamma-glutamyl carboxylase | Q70660173 | ||
Cofactor dependence of factor Xa incorporation into the prothrombinase complex | Q70797609 | ||
New protein sequenator with increased sensitivity | Q71130683 | ||
The Molecular Weights of Bovine Thrombin and Its Primary Autolysis Products | Q71246320 | ||
Coordinate binding of factor Va and factor Xa to the unstimulated platelet | Q71440229 | ||
Purification and characterization of bovine tissue factor | Q71563279 | ||
Blood clotting in minimally altered whole blood | Q71735200 | ||
Isolation of a membrane-bound cofactor for thrombin-catalyzed activation of protein C | Q71857877 | ||
Bovine Factor X. II. Characterization of purified Factor X. Alterations in zone electrophoretic and chromatographic behavior occurring during purification | Q72162471 | ||
A model for the tissue factor pathway to thrombin. I. An empirical study | Q72181568 | ||
The preparation and properties of a stable factory V from bovine plasma | Q72335008 | ||
Purification and properties of bovine prothrombin | Q72510222 | ||
P433 | issue | 7 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 1293-1299 | |
P577 | publication date | 2010-07-01 | |
P1433 | published in | Arteriosclerosis, Thrombosis, and Vascular Biology | Q4797542 |
P1476 | title | Taking the thrombin "fork". | |
P478 | volume | 30 |
Search more.